Loomis Sayles & Co. L P Increases Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Loomis Sayles & Co. L P boosted its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 22.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,619,320 shares of the construction company’s stock after acquiring an additional 300,076 shares during the quarter. Loomis Sayles & Co. L P owned about 1.97% of Aspen Aerogels worth $44,839,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in shares of Aspen Aerogels by 5.1% during the first quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after buying an additional 175,906 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in Aspen Aerogels by 15.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 14,580 shares of the construction company’s stock worth $257,000 after purchasing an additional 1,938 shares during the period. Silvercrest Asset Management Group LLC lifted its position in shares of Aspen Aerogels by 48.0% during the first quarter. Silvercrest Asset Management Group LLC now owns 478,193 shares of the construction company’s stock worth $8,416,000 after purchasing an additional 155,110 shares during the last quarter. California State Teachers Retirement System lifted its position in shares of Aspen Aerogels by 8.6% during the first quarter. California State Teachers Retirement System now owns 60,039 shares of the construction company’s stock worth $1,057,000 after purchasing an additional 4,734 shares during the last quarter. Finally, Comerica Bank purchased a new stake in shares of Aspen Aerogels during the first quarter valued at $1,992,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Stock Up 5.1 %

ASPN stock opened at $15.05 on Tuesday. The firm has a 50 day moving average of $20.88 and a 200 day moving average of $24.23. The stock has a market capitalization of $1.23 billion, a PE ratio of 1,506.01 and a beta of 2.21. Aspen Aerogels, Inc. has a 52 week low of $10.31 and a 52 week high of $33.15. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Insider Activity at Aspen Aerogels

In related news, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares in the company, valued at $14,523,709.20. This represents a 11.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 4.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. HC Wainwright reiterated a “buy” rating and set a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. Roth Mkm reduced their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. Barclays decreased their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. TD Cowen increased their price target on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Finally, Piper Sandler dropped their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Aspen Aerogels has an average rating of “Moderate Buy” and a consensus target price of $28.70.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.